PreveCeutical Medical Inc. (FRA:18H0)

Germany flag Germany · Delayed Price · Currency is EUR
0.0080
-0.0030 (-27.27%)
Last updated: Dec 1, 2025, 8:19 AM CET
-30.43%
Market Cap9.20M
Revenue (ttm)n/a
Net Income (ttm)-1.62M
Shares Outn/a
EPS (ttm)-0.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0080
Previous Close0.0110
Day's Range0.0080 - 0.0080
52-Week Range0.0080 - 0.0300
Betan/a
RSI40.07
Earnings DateDec 5, 2025

About PreveCeutical Medical

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development programs include dual gene therapy for curative and prevention therapies for diabetes and obesity; the Sol-gel Program; Nature Identical peptides for treatment of various ailments; nonaddictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating ... [Read more]

Industry Pharmaceutical Preparations
CEO Stephen Van Deventer
Country Canada
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 18H0
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements

News

There is no news available yet.